Sort by
Refine Your Search
-
The Leibniz Institute of Plant Biochemistry invites applications to fill the position of PostDoc Researcher for Metabolomic and Proteomic Analysis (m/f/d) (Salary group E13 TV-L,working hours 100
-
projects focused on studying the molecular mechanisms of arrhythmias with emphasis on conduction system diseases. To identify these pathways, the postdoctoral fellow will use mouse models for different
-
. Desired: Experience in tRNA and protein purification, in vitro transcription of RNA, gel electrophoresis, chromatography, mass spectrometry/proteomics, Trypanosoma brucei and mammalian cell culture, and
-
Max Planck Institute for Brain Research, Frankfurt am Main | Frankfurt am Main, Hessen | Germany | about 4 hours ago
culture A highly collaborative and international research environment at the MPI for Brain Research, a globally renowned institution where around 40% of scientists are from abroad and 40 different countries
-
, epidemiology, biostatistics, genomics, big data analytics, or artificial intelligence analytics Be familiar with conducting analysis with different types of data, including metagenomics sequencing, genomics
-
integrate in vivo mouse models and proteomics via mass spectrometry to uncover mechanisms of immune reprogramming and therapeutic response. Minimum Qualifications: PhD in Biomedical Sciences, Bioengineering
-
invites applications for a one-year postdoc position, focusing on protein biology involved in the energy metabolism of neuronal synapses. The candidate is expected to use cutting-edge proteomics and super
-
invites applications for a one-year postdoc position, focusing on protein biology involved in the energy metabolism of neuronal synapses. The candidate is expected to use cutting-edge proteomics and super
-
, molecular, behavioural and environmental determinants of non-communicable diseases, ultimately benefiting patients and society. The Centre owns exceptionally rich genetic and molecular (especially proteomic
-
, molecular, behavioural and environmental determinants of non-communicable diseases, ultimately benefiting patients and society. The Centre owns exceptionally rich genetic and molecular (especially proteomic